›› 2014, Vol. 29 ›› Issue (3): 297-300.DOI: 10.3969/j.issn.1673-8640.2014.03.024
• Orginal Article • Previous Articles Next Articles
CHEN Hongwei,LIANG Dongyu,HOU Yanqiang.
Received:2013-05-13
Online:2014-03-30
Published:2014-04-19
CLC Number:
CHEN Hongwei, LIANG Dongyu, HOU Yanqiang.. Laboratory diagnosis for sepsis and its research advance[J]. , 2014, 29(3): 297-300.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2014.03.024
| [1] Gonsalves MD,Sakr Y. Early identification of sepsis[J]. Curr Infect Dis Rep,2010,12(5):329-335. [2] Bauer M,Reinhart K. Molecular diagnostics of sepsis-where are we today[J]. Int J Med Microbiol,2010,300(6):411-413. [3] Sankar V,Webster NR. Clinical application of sepsis biomarkers[J].J Anesth,2013,27(2):269-283. [4] Waring WS,Moonie A. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury[J]. Clin Toxicol (Phila),2011,49(8):720-728. [5] Oncel MY,Dilmen U,Erdeve O,et al.Proad-renomedullin as a prognostic marker in neonatal sepsis[J]. Pediatr Res,2012,72(5):507-512. [6] Pedersen T,Roikjaer O,Jess P. Increased levels of C-reactive protein and leukocyte count are poor predictors of anastomotic leakage following laparoscopic colorectal resection[J]. Dan Med J,2012,59(12):A4552. [7] Vincent JL,Donadello K,Schmit X. Biomarkers in the critically ill patient: C-reactive protein[J].Cri Care Clin,2011,27(2):241-251. [8] MclLwain RB,Timpa JG,Kurundkar AR,et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine[J]. Lab Invest,2010,90(1):128-139. [9] Kibe S,Adams K,Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care[J].J Antimicrob Chemother,2011,66 (Suppl 2):ii33-ii40. [10] Berg P,Lindhardt BØ.A procalcitonin-guided algorithm for pneumonia may reduce antibiotic use and treatment duration[J]. Ugeskr Laeger,2012,174(35):1986-1989. [11] Bielinski SJ,Reiner AP,Nickerson D,et al.Polymorphisms in the [12] Kowalska I,Borawski J,Nikolajuk A,et al. Insulin sensitivity,plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy[J]. Endocrine,2011,40(1):95-101. [13] Deneva-Koycheva TI,Vladimirova-Kitova LG,Angelova EA,et al.Serum levels of siCAM-1,sVCAM-1,sE-selectin,sP-selectin in healthy Bulgarian people[J].Folia Med,2011,53(2):22-28. [14] Hoenigl M,Raggam RB,Wagner J,et al.Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome[J].Clin Biochem ,2013,46(3):225-229. [15] Donadello K,Scolletta S,Covajes C,et al. suPAR as a prognostic biomarker in sepsis[J]. BMC Med,2012,10:2. [16] Savva A,Raftogiannis M,Baziaka F,et al.Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis[J].J Infect,2011,63(5):344-350. [17] Wagner J.Free DNA new potential analyte in clinical laboratory diagnostics[J].Biochem Med(Zagreb),2012,22(1):24-38. [18] 侯彦强,梁冬雨,彭 亮,等.分支链DNA Alu技术定量检测败血症患者血浆循环DNA的表达[J]. 检验医学,2012,27(12):1050-1053. [19] Moreira VG,Prieto B,Rodriguez JS,et al.Usefulness of cell-free plasma DNA,procalcitonin and C-reactive protein as markers of infection in febrile patients[J]. Ann Clin Biochem,2010,47(Pt 3):253-258. [20] Loens K,Bergs K,Ursi D,et al. Evaluation of NucliSens easyMAG for automated nucleic acid extraction from various clinical specimens[J]. J Clin Microbiol,2007,45(2):421-425. [21] Wu L,Li H,Jia CY,et al. MicroRNA-223 regulates FOXO1 expression and cell proliferation[J].FEBS Lett,2012,586(7):1038-1043. |
| [1] | MENG Huimin, YANG Junli, HAN Yongyan. Relationship between differential expression of gut microbiota structure and prognosis in patients with septic shock [J]. Laboratory Medicine, 2025, 40(5): 455-459. |
| [2] | ZHU Jing, ZHANG Rulin, WU Jun. Expressions of CCNB1,PTTG1 and CBX3 in hepatocellular carcinoma and their roles in prognostic assessment [J]. Laboratory Medicine, 2025, 40(4): 331-337. |
| [3] | MA Duan. Consideration and application of improving the positive detection rate of rare genetic disorders [J]. Laboratory Medicine, 2025, 40(2): 109-113. |
| [4] | WANG Guoyu, ZHAI Jianzhao, ZHONG Huiyu, LIU Tangyuheng, JIAO Lin, HE Yong, YING Binwu, WANG Minjin. Clinical phenotype and molecular genetic characteristics of adult Krabbe disease in China [J]. Laboratory Medicine, 2025, 40(2): 121-130. |
| [5] | LIU Fadi, LE Ping, WU Yinglong, LIU Huihua, YI Ting, FU Jingjing, KE Jiangwei. Sequencing analysis of hearing-impaired children with negative hearing loss gene screening results and carrying only a single heterozygous variant in GJB2 or SLC26A4 [J]. Laboratory Medicine, 2024, 39(12): 1202-1207. |
| [6] | MA Yan, ZHOU Chunmei, HUANG Shenglei, WANG Beili, PAN Baishen, GUO Wei. Application evaluation of 24 h satellite blood culture to improve pathogenic microorganism culture process in emergency [J]. Laboratory Medicine, 2024, 39(10): 993-998. |
| [7] | ZHANG Jing. Synergistic role of vitamin D and blood glucose in pregnancy outcomes in patients with preeclampsia [J]. Laboratory Medicine, 2024, 39(8): 779-786. |
| [8] | YANG Huilin, CHEN Juan, YAN Jinjin, OU Jiawen, WEN Mingming, ZHOU Lina. Analysis of 4 blood culture bottles' adsorption capacity to 4 commonly used antibiotics [J]. Laboratory Medicine, 2024, 39(6): 578-582. |
| [9] | LI Anqi, ZHANG Shuya, HE Shanna, CHEN Qiaoqiao, LÜ Qi, LÜ Wanfei, LI Chunxian, WANG Weihua, ZHENG Lin. Rapid bacterial identification and drug susceptibility test of blood culture-positive samples [J]. Laboratory Medicine, 2024, 39(3): 243-248. |
| [10] | CHEN Yu, ZHAO Ya, WANG Lin. Microbial distribution and drug resistance in chronic dacryocystitis [J]. Laboratory Medicine, 2024, 39(3): 256-259. |
| [11] | . [J]. Laboratory Medicine, 2023, 38(7): 692-695. |
| [12] | FANG Yongmei, ZHANG Yan, XU Xueying, ZHONG Feng. Correlation of Staphylococcus aureus drug resistance with drug resistance genes and virulence genes [J]. Laboratory Medicine, 2023, 38(4): 357-361. |
| [13] | LIU Congcong, LI Jiaping, ZHOU Hongwei. Performance evaluation of 2 mass spectrometry systems in clinical microbial identification [J]. Laboratory Medicine, 2022, 37(11): 1084-1088. |
| [14] | . [J]. Laboratory Medicine, 2022, 37(10): 952-954. |
| [15] | LI Renqiang, LUO Junfeng, CHEN Yundi. Establishment and evaluation of α-thalassemia and β-thalassemia mutation determinations using hetero-tail dual-labeled fluorescent probe hydridization [J]. Laboratory Medicine, 2022, 37(10): 955-962. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||